195 related articles for article (PubMed ID: 26266379)
1. A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease.
Chen YC; Hwang SJ; Li CY; Wu CP; Lin LC
Medicine (Baltimore); 2015 Aug; 94(32):e1334. PubMed ID: 26266379
[TBL] [Abstract][Full Text] [Related]
2. Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan.
Lin SY; Chen TC; Lu PL; Lin CY; Lin WR; Yang YH; Chen YH
BMC Infect Dis; 2014 Dec; 14():705. PubMed ID: 25523602
[TBL] [Abstract][Full Text] [Related]
3. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.
Hsu CS; Kao JH; Chao YC; Lin HH; Fan YC; Huang CJ; Tsai PS
Aliment Pharmacol Ther; 2013 Aug; 38(4):415-23. PubMed ID: 23802888
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD.
Park H; Chen C; Wang W; Henry L; Cook RL; Nelson DR
Hepatology; 2018 Feb; 67(2):492-504. PubMed ID: 28873225
[TBL] [Abstract][Full Text] [Related]
5. Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.
Tung CH; Lai NS; Li CY; Tsai SJ; Chen YC; Chen YC
BMJ Open; 2018 Jul; 8(7):e021747. PubMed ID: 30037875
[TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals.
Chen YC; Li CY; Tsai SJ; Chen YC
World J Clin Cases; 2019 Jun; 7(11):1270-1281. PubMed ID: 31236391
[TBL] [Abstract][Full Text] [Related]
7. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
Hsu YC; Lin JT; Ho HJ; Kao YH; Huang YT; Hsiao NW; Wu MS; Liu YY; Wu CY
Hepatology; 2014 Apr; 59(4):1293-302. PubMed ID: 24122848
[TBL] [Abstract][Full Text] [Related]
8. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
Chen YC; Li CY; Tsai SJ; Chen YC
World J Gastroenterol; 2018 Feb; 24(8):917-928. PubMed ID: 29491685
[TBL] [Abstract][Full Text] [Related]
9. Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Chou SM; Yeh HJ; Lin TM; Chang YS; Hsu HC; Shen YC; Kuo TT; Chen JH; Chen SC; Chang CC
Front Immunol; 2022; 13():992819. PubMed ID: 36275719
[TBL] [Abstract][Full Text] [Related]
10. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Feb; 49(3):331-339. PubMed ID: 30592071
[TBL] [Abstract][Full Text] [Related]
11. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
Lin MS; Chen TH; Lin WY; Liu CH; Hsieh YY; Chiu WN; Chang CH; Chen MY; Chung CM; Lin YS
BMC Gastroenterol; 2017 Aug; 17(1):99. PubMed ID: 28814273
[TBL] [Abstract][Full Text] [Related]
12. Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.
Hsu CS; Huang CJ; Kao JH; Lin HH; Chao YC; Fan YC; Tsai PS
PLoS One; 2013; 8(7):e70458. PubMed ID: 23894660
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
Wu CM; Su FH; Muo CH; Huang JC; Wu MM; Yeh CC
Viruses; 2021 Mar; 13(3):. PubMed ID: 33799370
[TBL] [Abstract][Full Text] [Related]
14. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.
Chen YC; Chiou WY; Hung SK; Su YC; Hwang SJ
BMC Nephrol; 2013 Sep; 14():187. PubMed ID: 24011024
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
Su TH; Tseng TC; Liu CJ; Chou SW; Liu CH; Yang HC; Chen PJ; Chen DS; Chen CL; Kao JH
Int J Cancer; 2020 Aug; 147(3):901-908. PubMed ID: 31853972
[TBL] [Abstract][Full Text] [Related]
17. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
[TBL] [Abstract][Full Text] [Related]
18. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection - A Nationwide Cohort Study.
Lin MS; Chung CM; Chang ML; Chen MY; Chang ST; Chu PH; Chen TH; Lin WY; Huang TJ; Lin YS
Circ J; 2018 May; 82(6):1623-1631. PubMed ID: 29503408
[TBL] [Abstract][Full Text] [Related]
19. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.
Chen YC; Su YC; Li CY; Hung SK
BMC Nephrol; 2015 Jul; 16():110. PubMed ID: 26199000
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
Liu CJ; Chu YT; Shau WY; Kuo RN; Chen PJ; Lai MS
Gut; 2014 Mar; 63(3):506-14. PubMed ID: 23676440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
